Company / PP&E (Net)
Enovis PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$507.1M
FY2025
5-year range
$235.1M / $507.1M
FY2021-FY2025
Trend
+25.4%
vs FY2024
Sector context
#52 of 132
Health Care
What the data says
At $507M, Enovis's pp&e (net) ranks #52 of 132 in the Health Care sector. PP&E (Net) has increased for 4 consecutive years, from $235M in FY2021 to $507M in FY2025.
Based on SEC 10-K filings.
$507M in FY2025 with a 5-year CAGR of +0.8%.
Improved from $271M to $507M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +28.9%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
#52 of 132 in Health CareTop 39% of 132This company $507.1M Sector average $1.4B
▼
-64.7% below sector average
Key checks
Key Insights
- Enovis's pp&e (net) has grown for 4 consecutive years.
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2025, pp&e (net) increased 25.4% year-over-year.
- Ranks #52 out of 132 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $507.1M | +25.4% |
| FY2024 | $404.5M | +49.4% |
| FY2023 | $270.8M | +14.4% |
| FY2022 | $236.7M | +0.7% |
| FY2021 | $235.1M | -51.7% |
| FY2020 | $487.0M | -0.9% |
| FY2019 | $491.2M | +50.2% |
| FY2018 | $327.2M | -40.8% |
| FY2017 | $552.8M | +9.4% |
| FY2016 | $505.4M | -21.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026